<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//www.ivybraintumorcenter.org/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://www.ivybraintumorcenter.org/brain-tumor-clinical-trials/current-trials/radiation-therapy-vs-observation-for-newly-diagnosed-meningioma/</loc>
		<lastmod>2023-07-05T23:14:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/brain-tumor-clinical-trials/current-trials/radiation-therapy-planning-with-fluciclovine-pet-for-newly-diagnosed-glioblastoma/</loc>
		<lastmod>2023-08-04T00:00:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/brain-tumor-clinical-trials/current-trials/smo-akt-nf2-cdk-ihibitors-for-progressive-meningiomas/</loc>
		<lastmod>2023-08-30T17:48:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/brain-tumor-clinical-trials/current-trials/radiation-therapy-for-brain-metastases/</loc>
		<lastmod>2024-02-07T15:16:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/brain-tumor-clinical-trials/current-trials/abemaciclib-in-newly-diagnosed-meningioma-patients/</loc>
		<lastmod>2025-06-11T22:22:30+00:00</lastmod>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2020/06/How-it-works_2@4x.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2023/06/Ivy_Web_Icon_Phase3.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2020/06/How-it-works_3@4x.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2023/03/Ivy_FollowUp_Visit_Icon_Alt-1.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/brain-tumor-clinical-trials/current-trials/safusidenib-ab-218-for-idh1-mutant-glioma/</loc>
		<lastmod>2026-02-02T21:20:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/brain-tumor-clinical-trials/current-trials/silevertinib-bdtx-1535-for-high-grade-glioma-and-glioblastoma/</loc>
		<lastmod>2026-02-26T21:52:26+00:00</lastmod>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2025/06/iStock-1453661990.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2020/06/How-it-works_1@4x.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2020/06/How-it-works_2@4x.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2020/06/How-it-works_3@4x.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2020/06/How-it-works_4@4x.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/brain-tumor-clinical-trials/current-trials/gsk5764227-in-recurrent-grade-4-glioma-and-in-brain-metastases/</loc>
		<lastmod>2026-02-26T21:58:47+00:00</lastmod>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2026/02/GKS227.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2020/06/How-it-works_1@4x.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2020/06/How-it-works_2@4x.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2020/06/How-it-works_3@4x.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2020/06/How-it-works_4@4x.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/brain-tumor-clinical-trials/current-trials/quisinostat-for-glioblastoma/</loc>
		<lastmod>2026-02-26T22:01:12+00:00</lastmod>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2025/07/iStock-2140593067.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2020/06/How-it-works_1@4x.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2020/06/How-it-works_2@4x.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2020/06/How-it-works_3@4x.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2020/06/How-it-works_4@4x.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/brain-tumor-clinical-trials/current-trials/emavusertib-ca-4948-in-relapsed-primary-central-nervous-system-lymphoma/</loc>
		<lastmod>2026-02-26T22:05:36+00:00</lastmod>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2025/08/iStock-1385054127-scaled.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2025/08/HIW-Patient.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2025/08/HIW-Meds.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2025/08/HIW-Meds.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2025/08/HIW-Patient.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2025/08/HIW-Meds.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2025/08/HIW-Meds.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2025/08/HIW-Meds.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2025/08/HIW-Timer.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/brain-tumor-clinical-trials/current-trials/bms-986504-in-recurrent-glioblastoma/</loc>
		<lastmod>2026-02-26T22:09:09+00:00</lastmod>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2025/04/iStock-2155983002-scaled.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2020/06/How-it-works_1@4x.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2020/06/How-it-works_2@4x.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2020/06/How-it-works_3@4x.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/wp-content/uploads/2020/06/How-it-works_4@4x.png</image:loc>
		</image:image>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->